Galmed Pharmaceuticals
GLMD
#10210
Rank
A$7.81 M
Marketcap
$4.72
Share price
5.02%
Change (1 day)
-36.00%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$10.10

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$10.77. In 2022 the company made an earnings per share (EPS) of -$17.01 an increase over its 2021 EPS that were of -$31.87.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$10.10-40.64%
2022-$17.01-46.62%
2021-$31.87-2.22%
2020-$32.5939.18%
2019-$23.4270.18%
2018-$13.76-41.84%
2017-$23.66-34.23%
2016-$35.9756.84%
2015-$22.939.2%
2014-$21.00-53.43%
2013-$45.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.08-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.47-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.21-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.80-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA